Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resectable Lung Non-Small Cell Carcinoma”

291 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 291 results

Testing effectiveness (Phase 2)Study completedNCT00039507
What this trial is testing

Radiofrequency Ablation During Surgery in Treating Patients With Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Fox Chase Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT04379739
What this trial is testing

Neoadjuvant PD-1 Antibody Plus Apatinib or Chemotherapy for Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 89
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07231575
What this trial is testing

Neoadjuvant SBRT and Tislelizumab (Immunotherapy) Plus Anlotinib for Resectable EGFR Wild-type NSCLC

Who this might be right for
Neoadjuvant ImmunotherapyNSCLCChemo-free Therapy
Sun Yat-sen University 39
Not applicableLooking for participantsNCT04973293
What this trial is testing

Preoperative Sintilimab Combined With Bevacizumab and Chemotherapy for Resectable Non-Small Cell Lung Cancer

Who this might be right for
Lung Neoplasm Malignant
Ruijin Hospital 20
Large-scale testing (Phase 3)Looking for participantsNCT06312137
What this trial is testing

Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

Who this might be right for
Non Small Cell Lung Cancer
Merck Sharp & Dohme LLC 780
Not applicableLooking for participantsNCT06448793
What this trial is testing

Patient and Physician Preference Study in Resectable, Non-small Cell Lung Cancer Treatments

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Bristol-Myers Squibb 55
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04846634
What this trial is testing

Penpulimab-based Combination Neoadjuvant/Adjuvant Therapy for Patients With Resectable Locally Advanced Non-small Cell Lung Cancer: a Phase II Clinical Study (ALTER-L043)

Who this might be right for
Resectable Locally Advanced Non-small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital 90
Large-scale testing (Phase 3)Not Yet RecruitingNCT06485557
What this trial is testing

A Prospective Cohort Study of Neoadjuvant Chemotherapy Plus Sintillumab in the Treatment of Resectable NSCLC

Who this might be right for
Resectable Non-small Cell Lung Cancer
Tang-Du Hospital 90
Testing effectiveness (Phase 2)Study completedNCT01076231
What this trial is testing

Proton Beam Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Can Be Removed By Surgery

Who this might be right for
Stage IIIA Non-small Cell Lung Cancer
Abramson Cancer Center at Penn Medicine 34
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06109402
What this trial is testing

Perioperative Immunotherpay Versus Adjuvant Immunotherapy for Resectable Non-small Cell Lung Cancer

Who this might be right for
Stage II-IIIB(N2) Non-small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 160
Large-scale testing (Phase 3)Active Not RecruitingNCT04351555
What this trial is testing

Osimertinib With or Without Chemotherapy Versus Chemotherapy Alone as Neoadjuvant Therapy for Patients With EGFRm Positive Resectable Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
AstraZeneca 358
Not applicableNot Yet RecruitingNCT06287593
What this trial is testing

The Feasibility of Dynamic Liquid Biopsy Monitoring During Neoadjuvant Treatment for EGFR-mutated NSCLC

Who this might be right for
EGF-R Positive Non-Small Cell Lung Cancer
Zhejiang University 300
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06018688
What this trial is testing

Osimertinib Combined With Aspirin Neoadjuvant Therapy for Resectable EGFR Mutated NSCLC Patients.

Who this might be right for
Non Small Cell Lung CancerEGFR Gene Mutation
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 44
Testing effectiveness (Phase 2)Looking for participantsNCT06088771
What this trial is testing

Neoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Icahn School of Medicine at Mount Sinai 21
Testing effectiveness (Phase 2)Study completedNCT00963807
What this trial is testing

A Comparison of FLT to FDG PET/CT in the Early Assessment of Chemotherapy Response in Stage IB-IIIA Resectable NSCLC

Who this might be right for
Recurrent Non-Small Cell Lung CarcinomaStage IB Non-Small Cell Lung CarcinomaStage IIA Non-Small Cell Lung Carcinoma+3 more
National Cancer Institute (NCI) 26
Testing effectiveness (Phase 2)Study completedNCT00198367
What this trial is testing

Three Modalities of Treatment in Operable and Resectable Stage IIIA (T1-3, N2) Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
Hospices Civils de Lyon 120
Testing effectiveness (Phase 2)Study completedNCT00463515
What this trial is testing

Evaluation of Carboplatin Plus Gemcitabine Followed by Concomitant Chemoradiation for Non-resectable Stage III NSCLC

Who this might be right for
Non-Small-Cell-Lung Cancer
University Hospital, Antwerp 77
Not applicableNot Yet RecruitingNCT06613308
What this trial is testing

Association Between Microbiome and the Efficacy and Safety of PD-1/PD-L1 Blockade in Resectable NSCLC

Who this might be right for
Lung Cancer (NSCLC)
Capital Medical University 20
Testing effectiveness (Phase 2)Study completedNCT02994576
What this trial is testing

Atezolizumab as Induction Therapy in Non-small Cell Lung Cancer

Who this might be right for
Nonsmall Cell Lung Cancer
Gustave Roussy, Cancer Campus, Grand Paris 60
Post-approval studies (Phase 4)Ended earlyNCT05583188
What this trial is testing

Neoadjuvant Aliya™ PEF Soft Tissue Ablation With Systemic Therapy in Early-Stage Resectable NSCLC

Who this might be right for
NSCLC
Galvanize Therapeutics, Inc. 5
Load More Results